<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01325597</url>
  </required_header>
  <id_info>
    <org_study_id>UP 4546/10</org_study_id>
    <nct_id>NCT01325597</nct_id>
  </id_info>
  <brief_title>Effects of Functional Electrical Stimulation and Inspiratory Muscle Training in Heart Failure Patients</brief_title>
  <official_title>Effects of Functional Electrical Stimulation and Inspiratory Muscle Training in Heart Failure Patients: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Cardiologia do Rio Grande do Sul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto de Cardiologia do Rio Grande do Sul</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effects of functional electrical stimulation
      associated with inspiratory muscle training on functional capacity and quality of life in
      heart failure patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the effects of the functional electrical stimulation (FES)
      associated with inspiratory muscle training (IMT) on functional capacity and quality of life
      in patients with heart failure (HF). A randomized clinical trial with 60 HF patients
      (functional class II-IV) will be randomly assigned to the FES, IMT, IMT associated with FES
      or control group. FES will be applied at 15 Hz, 0.4 ms pulse width, 10-s contraction time,
      50-s resting time and maximum tolerable intensity, 3 sessions per week, for 12 weeks. The IMT
      will also be performed for 12 weeks, 5 sessions per week, with an intensity of 30% of maximal
      inspiratory pressure. Acute and chronic effects of interventions on functional capacity,
      quality of life, peripheral muscle strength, pulmonary function, respiratory muscle strength
      and endurance, endothelial function, autonomic control and oxidative stress will be analyzed
      in these patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on functional capacity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral muscle strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on peripheral muscle strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on pulmonary function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscle strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on respiratory muscle strength.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on endothelial function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Autonomic control</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on autonomic control.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>12 weeks</time_frame>
    <description>To assess the effects of the functional electrical stimulation (FES) associated with inspiratory muscle training (IMT) on oxidative stress.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Combined training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Training with functional electrical stimulation added by inspiratory muscle training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FES will be applied at 15 Hz, 0.4 ms pulse width, 10-s contraction time, 50-s resting time and maximum tolerable intensity, 3 sessions per week, for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IMT will be performed for 12 weeks, 5 sessions per week, with an intensity of 30% of maximal inspiratory pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Combined training</intervention_name>
    <description>FES will be applied at 15 Hz, 0.4 ms pulse width, 10-s contraction time, 50-s resting time and maximum tolerable intensity, 3 sessions per week, for 12 weeks. The IMT will also be performed for 12 weeks, 5 sessions per week, with an intensity of 30% of maximal inspiratory pressure.</description>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
    <other_name>Electric stimulation</other_name>
    <other_name>Electrical stimulation</other_name>
    <other_name>Inspiratory muscle training</other_name>
    <other_name>Breathing exercises</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electrical stimulation</intervention_name>
    <description>FES will be applied at 15 Hz, 0.4 ms pulse width, 10-s contraction time, 50-s resting time and maximum tolerable intensity, 3 sessions per week, for 12 weeks</description>
    <arm_group_label>Combined training</arm_group_label>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
    <other_name>Electric stimulation</other_name>
    <other_name>Eletric stimulation therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspiratory muscle training</intervention_name>
    <description>IMT will be performed for 12 weeks, 5 sessions per week, with an intensity of 30% of maximal inspiratory pressure</description>
    <arm_group_label>Combined training</arm_group_label>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <other_name>Respiratory muscle training</other_name>
    <other_name>Breathing exercises</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Combined training</arm_group_label>
    <arm_group_label>Electrical stimulation</arm_group_label>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with stable heart failure and New York Heart Association (NYHA) class II-IV

          -  Aged 30-70 years

          -  Left ventricular ejection fraction less than 35% determined by echocardiography and
             optimized pharmacological treatment (unchanged 1 month prior to study)

        Exclusion Criteria:

          -  Patients with unstable heart failure

          -  NYHA class I

          -  Unstable angina pectoris and ventricular arrhythmia

          -  Implanted cardiac pacemaker

          -  Acute pulmonary diseases

          -  Chronic renal failure or dialysis

          -  Acute myocardial infarction 3 months before the inclusion in the study

          -  Acute inflammatory diseases

          -  Peripheral vascular disease

          -  Neurologic disease

          -  Musculoskeletal pathologies

          -  Malignancies or being an active smoker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo DM Plentz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo DM Plentz, PhD</last_name>
    <phone>+ 55 51 91794399</phone>
    <email>roplentz@yahoo.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Graciele Sbruzzi, MSc</last_name>
    <phone>+ 55 51 98899705</phone>
    <email>graci_sbruzzi@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90.620-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo DM Plentz, PhD</last_name>
      <phone>+ 55 51 32192802</phone>
      <email>roplentz@yahoo.com.br</email>
    </contact>
    <contact_backup>
      <last_name>Graciele Sbruzzi, MSc</last_name>
      <phone>+ 55 51 32232746</phone>
      <email>graci_sbruzzi@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2011</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2011</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto de Cardiologia do Rio Grande do Sul</investigator_affiliation>
    <investigator_full_name>Graciele Sbruzzi</investigator_full_name>
    <investigator_title>Doutora</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Electric stimulation</keyword>
  <keyword>Breathing exercises</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

